🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Long-Term Follow-Up of Patients who Received Placebo

Found 13 matching trials

A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

PHASE3

The main purpose of this study is to evaluate how effective and safe the st...

Status

Completed

Location

Rheumatology Associates PC

Start Date

2014-12-31

Trial ID

NCT02349295

Treatments Being Tested

Placebo Ixekizumab 80 mg Q4W Ixekizumab 80 mg Q2W

Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome

PHASE4

The purpose of this large multicenter, randomized, double-blinded, controll...

Status

Unknown

Location

Peking University People's Hospital

Start Date

2015-03

Trial ID

NCT02370550

Treatments Being Tested

Cyclosporin A Prednisone Placebo Calcium carbonate D

An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))

PHASE3

The purpose of this study is to evaluate the effects of losartan on protein...

Status

Completed

Location

Multiple Locations

Start Date

2007-06-01

Trial ID

NCT00568178

Treatments Being Tested

Losartan Potassium Comparator: Placebo (Losartan)Comparator: amlodipine besylate Comparator: Placebo (amlodipine besylate)Placebo (Losartan)Enalapril Maleate

Impact of a Telemonitoring Program on the Rate of Hospitalizations for Worsening of Cardio-respiratory Symptoms in COPD Patients Treated at Home by Long-term Non-invasive Ventilation (NIV)

COPD is characterized by non-reversible chronic airway obstruction. Its evo...

Status

Terminated

Location

Grenoble University Hospital

Start Date

2016-08

Trial ID

NCT02756533

Treatments Being Tested

Telemonitoring of daily parameters recorded by NIV Placebo

Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients

PHASE3

1. Conduct a large-sample, multicenter, superiority, double-blind, randomiz...

Status

Enrolling By Invitation

Location

Guangdong Provincial Hospital of Traditional Chinese Medicine

Start Date

2025-04-24

Trial ID

NCT06908473

Treatments Being Tested

Participants will receive Tongmai Jiangtang Capsule (TJC) in addition to standard treatment.A placebo capsule that is identical in appearance, size, color, formulation, weight, taste, and smell to TJC

The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran)

PHASE3

The purpose of this study is to evaluate the safety and efficacy of long-te...

Status

Completed

Location

Clinical Trial Site

Start Date

2015-07-16

Trial ID

NCT02510261

Treatments Being Tested

Patisiran

Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy

PHASE3

The purpose of this study is to explore the overall safety profile and dura...

Status

Completed

Location

Arizona Research Center

Start Date

2019-02-04

Trial ID

NCT04055090

Treatments Being Tested

Long-Term Follow-Up of Patients who Received Engensis (VM202)Long-Term Follow-Up of Patients who Received Placebo

An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203

PHASE3

This extension study will provide data to further evaluate the efficacy, sa...

Status

Completed

Location

Novartis Investigative Site

Start Date

2015-11-02

Trial ID

NCT02573467

Treatments Being Tested

Bimagrumab Placebo

Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).

N/A

This is a long-term observational study of patients that were treated with ...

Status

Completed

Location

Multiple Locations

Start Date

2006-06

Trial ID

NCT00741325

Treatments Being Tested

granulocyte colony-stimulating factor (G-CSF)plerixafor Placebo

An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of RO7234292 (RG6042) in Huntington's Disease Participants Who Participated in Prior Roche and Genentech Sponsored Studies

PHASE3

This study will evaluate the long-term safety and tolerability of RO7234292...

Status

Completed

Location

Uab Medicine

Start Date

2019-04-23

Trial ID

NCT03842969

Treatments Being Tested

RO7234292 (RG6042)

Previous Next